Europe Hematologic Malignancies Market Size & Outlook
The hematologic malignancies market in Europe is expected to reach a projected revenue of US$ 33,030.4 million by 2030. A compound annual growth rate of 7.8% is expected of Europe hematologic malignancies market from 2024 to 2030.
Revenue, 2023 (US$M)
$19,717.5
Forecast, 2030 (US$M)
$33,030.4
CAGR, 2024 - 2030
7.8%
Report Coverage
Europe
Europe hematologic malignancies market highlights
- The Europe hematologic malignancies market generated a revenue of USD 19,717.5 million in 2023.
- The market is expected to grow at a CAGR of 7.8% from 2024 to 2030.
- In terms of segment, leukemia was the largest revenue generating disease in 2023.
- Leukemia is the most lucrative disease segment registering the fastest growth during the forecast period.
Europe data book summary
| Market revenue in 2023 | USD 19,717.5 million |
| Market revenue in 2030 | USD 33,030.4 million |
| Growth rate | 7.8% (CAGR from 2024 to 2030) |
| Largest segment | Leukemia |
| Fastest growing segment | Leukemia |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Leukemia |
| Key market players worldwide | Pfizer Inc, F. Hoffmann-La Roche Ltd., Sanofi SA, Bristol-Myers Squibb Company, AbbVie Inc, Novartis AG, GlaxoSmithKline, Amgen Inc, Takeda Pharmaceutical Co Ltd, Johnson & Johnson |
Other key industry trends
- In terms of revenue, Europe region accounted for 29.3% of the global hematologic malignancies market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 28,622.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Hematologic Malignancies Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Bristol-Myers Squibb Company | View profile | - | - | - |
| Novartis AG | View profile | - | - | - |
| F. Hoffmann-La Roche Ltd. | View profile | - | - | - |
| GlaxoSmithKline | View profile | 10001+ | London, England, United Kingdom, Europe | http://www.gsk.com |
| Takeda Pharmaceutical Co Ltd | View profile | 49095 | 1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, Japan, 103-8668 | https://www.takeda.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
| Amgen Inc | View profile | 26700 | One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 | https://www.amgen.com |
| Johnson & Johnson | View profile | 134400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | https://www.jnj.com |
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
